Search
User Profile
Change
Select your user profile

Elecsys® Alzheimer’s Disease CSF Testing Sites

 

FDA-cleared cerebrospinal fluid biomarkers to support early diagnosis of Alzheimer’s

About the Elecsys® Alzehimer’s CSF Assays

The Elecsys® β-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF and Elecsys® tTau CSF assays are FDA-cleared in vitro electrochemiluminescence immunoassays for the measurement of the β-Amyloid (1-42) (Abeta42), Phospho-Tau (181P) (pTau181), respectively total-Tau protein concentrations in cerebrospinal fluid (CSF) from adult patients aged 55 years and older being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment to generate a pTau181/Abeta42 ratio, respectively a total-Tau/Abeta42 ratio value.¹

Here are the laboratories offering the Elecsys® Alzheimer’s CSF tests for send-out orders:

ARUP Laboratories

500 Chipeta Way
Salt Lake City, UT 84108
Test(s) Offered: pTau181/AB42; tTau/AB42
Test Order ID: 3017653
https://ltd.aruplab.com/Tests/Pub/3017653

Clinical Pathology Laboratories

9200 Wall St.
Austin, TX 78754
Test(s) Offered: pTau181/AB42; tTau/AB42
Test Order ID: 3015
https://www.cpllabs.com/clinicians/client-communications/ad-eval/

Labcorp

531 S. Spring St.
Burlington, NC 27215
Test(s) Offered: pTau181/AB42; tTau/AB42
Test Order ID: 484415
https://www.labcorp.com/tests/484415/alzheimer-s-disease-evaluation-profile-csf

Mayo Clinic Laboratories

3050 Superior Drive NW
Rochester, MN 55905
Test(s) Offered: pTau181/AB42
Test Order ID: ADEVL
https://www.mayocliniclabs.com/test-catalog/overview/607273

Have a lab running Elecsys® Alzheimer’s CSF assays?
 

Fill out this form to have your lab featured here.

 

Here is how your information will look when featured: 

Example Lab

123 Maple Street
City, State, Zip Code
Test(s) Offered: pTau181/AB42 and/or tTau/AB42
Test Order ID: 12345
https://www.examplelab.com/testpage (link to test page on your website)

 

Form Successfully Submitted!
Thank you for your submission!
text
close

Notes

  • A positive pTau181/Abeta42 or tTau/Abeta42 ratio result in CSF does not establish a diagnosis of Alzheimer’s disease (AD) and should always be interpreted in conjunction with clinical information.

  • The performance of the test for African-American, Asian, and other races had high uncertainty due to the limited number of patients studied.

 

Reference

  1. Elecsys® Method Sheet: ms_08821941190, ms_08846693160, ms_08846685190